Skip to main content
. 2020 Nov 3;10:18926. doi: 10.1038/s41598-020-76141-y

Table 1.

Patients with clinical data and Statistics results.

Characteristics All cases (n = 319)
Severe (n = 83) Moderate (n = 136) Control (n = 100) P-value#
General data
Age 49.46 ± 11.95 51.86 ± 13.63 50.96 ± 11.20 0.382
Gender
Male (female) 48(35) 79(57) 57(43) 0.078
Smoke
Yes (No) 21(62) 30(106) 31(69) 2.422
Symptom
Temperature (℃)
 > 37.3 (< 37.3) 26(57) 38(98) (100) 0.593
Cough
Yes (No) 63(20) 88(48) 4(96) 0.065
Sore throat
Yes (No) 59(24) 94(42) 3(97) 0.674
Sputum
Yes (No) 45(38) 79(57) 15(85) 0.575
Dyspnea
Yes (No) 14(69) 25(111) 2(98) 0.000
Muscle soreness
Yes (No) 54(29) 71(65) 0(100) 0.026
Laboratory data
WBC (109/L)
4–10 (< 4 or > 10) 64(19) 95(41) 0(100) 0.199
Lymphocyte (109/L)
1.1–3.2(< 1.1) 28(55) 39(97) 100(0) 0.411
ALT (U/L)
 ≤ 40(> 40) 78(5) 119(17) 100(0) 0.095
AST (U/L)
 ≤ 40(> 40) 78(5) 117(19) 100(0) 0.070
CRP (mg/L)
 ≤ 10(> 10) 23(50) 48(88) 100(0) 0.563
FIB (g/L)
1.5–3.5 (> 3.5) 39 (44) 82(54) 100(0) 0.054
Ure (mmol/L)
 ≤ 7.1(> 7.1) 67(16) 102(34) 100(0) 0.342
Cre (umol/L)
 ≤ 106(> 106) 62(21) 101(35) 95(5) 0.968

#In symptom and laboratory data, the statistical values of the study group and the control group are significantly different, and the Chi square test only carries out the cross test within the study group.